Search News Database

News Search:
Category:
1 - 20 of 2100 Results
...Industrial Info is tracking more than $2 billion in projects involving general contractor Brasfield & Gorrie (Birmingham, Alabama)....
Active Projects Involving Brasfield & Gorrie Wednesday, October 16, 2019 Manufacturing
...Industrial Info is tracking more than $6.6 billion in projects involving engineering, procurement and construction (EPC) company Barton Malow Company (Southfield, Michigan)....
Active Projects Involving Barton Malow Tuesday, October 15, 2019 Power
...According to U.K. Secretary of State for Health and Social Care Matt Hancock, the current "reasonable worst-case" planning assumption is that the flow of goods across the English Channel could be reduced to 40-60% of current levels on the first day of Brexit, with the expectation the flow would improve to 50-70% after three months and then return to current levels after 12 months.

...
uk2020projectko Monday, October 14, 2019 Market Brief
...Industrial Info is tracking more than $3.4 billion worth of active projects in the U.S. and Canada involving engineering, procurement and construction (EPC) firm PCL Construction (Edmonton, Alberta)....
Active Projects Involving PCL Friday, October 11, 2019 Terminals
...Industrial Info is tracking 34 U.S. projects valued at a combined $3.18 billion that involve construction contractor Gray Construction Company (Lexington, Kentucky)....
Active Projects Involving Gray Construction Thursday, October 10, 2019 Manufacturing
...Consistent growth within the EU's pharmaceuticals market requires investments for modernization and upgrades....
2020eumodernization Tuesday, October 8, 2019 Market Brief
...The European Medicines Agency (EMA) and its European and international partners have strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide and in Europe.

...
apiseurope Monday, October 7, 2019 Market Brief
...Kpc Pharmaceuticals Incorporated has expanded its research and development (R&D) center in China's Yunnan province. The project is currently in the process of equipment procurement, and construction is scheduled to begin before the end of this year. See chart below for a summary of the project....
R&D Wednesday, October 2, 2019 Market Brief
...Industrial Info is tracking more than $18 billion worth of projects in China's Pharmaceutical & Biotech Industry. Click here for a list of projects. The ingredients and final formulation sectors account for the bulk of the investment, with 422 projects, valued at more than $2 billion. See graph below for investment by sector....
all projects Wednesday, October 2, 2019 Market Brief
...Industrial Info is tracking 1,670 projects worth $25.64 billion in active pharmaceutical ingredients (API) projects. Asia is the most active region. China has more than 350 projects value at $13.2 billion, while India has more than 550 API projects valued at $3.5 billion. Click here for a list of projects and see graph below for project count by country....
api c Tuesday, October 1, 2019 Market Brief
...Some of the world's largest pharmaceutical companies have committed £100 million ($124 million) to a ground-breaking genetics research project designed to tackle a wide range of common and chronic diseases including dementia, mental illness, cancer and heart disease....
  Monday, September 30, 2019 Pharmaceutical
...India is considering a removal of price caps on medicines made from locally produced ingredients, in a bid to promote domestic manufacturing and reduce the country's dependence on imported APIs...
India P&B 0919 Monday, September 30, 2019 Market Brief
...Industrial Info is tracking 88 projects worth more than $5.54 billion in China's Pharmaceutical-Biotech Industry final formulation sector. Click here for a list of projects. Guangdong leads the provinces in terms of investment, with about $1.13 billion, followed by Jiangsu, with about $680 million. See graph below for investment by province....
201909 final c Monday, September 30, 2019 Market Brief
...Dr. Reddy's Laboratories, India's leading pharmaceutical manufacturer, received approval earlier this month from South Korea's Ministry of Food and Drug Safety to undertake the third-phase clinical trial of its Rituximab biosimilar....
Dr Reddy 0919 Thursday, September 26, 2019 Market Brief
...According to the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), a consultation of CEOs in the pharmaceutical and biotech industries in South Korea will be held in Seoul on October 1 with the Investment and Development Agency of Ireland (IDA Ireland). As a state-sponsored organization that selects and invests in highly promising overseas companies, the IDA Ireland will help talented Korean companies make inroads into Ireland.

Currently, SK Biotech, one of Korea's leading pharmaceutical-biotech companies, is the first Korean company to invest in pharmaceutical manufacturing in Ireland, acquiring and operating an active pharmaceutical ingredients production plant of Bristol-Myers Squibb in Swords, Ireland....
  Thursday, September 26, 2019 Market Brief
...Industrial Info is tracking 88 active capital-spending projects in China's final-formulation drug sector, with an investment totaling about $5.6 billion...
China pharma FF 0919 Thursday, September 26, 2019 Market Brief
...India's market for medical devices is expected to reach $50 billion in value by 2025, as the country's healthcare sector is poised for threefold growth. Currently, India is counted among the top 20 global markets for medical devices and is the fourth-largest in Asia...
India P&B 0919 Wednesday, September 25, 2019 Market Brief
...Industrial Info is tracking 121 projects in China's Pharma/Bio Industry that have at least one third party vendor. The projects are worth $6.42 billion. Bidding is expected to peak late this year and early next year. Click here for a list of projects and see chart below for a breakdown by bidding document date....
vendor201909 Tuesday, September 24, 2019 Market Brief
...Industrial Info is tracking 88 projects in China's Pharma-Biotech Industry, worth $3.34 billion, that are set to begin construction in fourth-quarter 2019. Click here for a list. The Jiangsu, Anhui and Zhejiang provinces lead in overall investment, which includes projects for active pharmaceutical ingredients, final formulation, laboratories and medical devices....
kickoff 201909 Friday, September 20, 2019 Market Brief
...China's Jiangsu Suying Pharmaceutical Company Limited is planning a $141 million investment package for a grassroot active pharmaceutical ingredient (API) plant in Jiangsu, China. The facility will produce as much as 1,439 tons per year of APIs, and the company will releases main equipment RFQs and subcontractor bid documents in the fourth quarter....
api201909 jiangsu Friday, September 20, 2019 Market Brief
Your Free Member Resources
Free Member Resources »
IIR NavigatIIR »
Upcoming Market Outlooks »
Market Outlook Library »
Custom Industrial Forecasts »
Annual Outlook Products »
Custom Analytics Products »